Metraipolis › archive › dc_2376235f474f

Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? — Europe PMC PMID:42180098

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180098
DOI
10.3389/fonc.2026.1636348
License (as archived)
solo-consultazione
Archived
2026-11-02T16:54:54.531Z
SHA-256 of the archived text
2fd83dca8a0ef99f82150dcfeb41768419556295a86ed38f712d631ed948c046
Stable URL of this page
https://metraipolis.com/documento/dc_2376235f474f

How to cite

Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? — Europe PMC PMID:42180098 — Europe PMC (en), https://europepmc.org/article/MED/42180098 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2376235f474f (Metraipolis archive dc_2376235f474f, sha256 2fd83dca8a0ef99f82150dcfeb41768419556295a86ed38f712d631ed948c046)
BibTeX
@misc{dc2376235f474f,
  title = {Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? — Europe PMC PMID:42180098},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180098},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2376235f474f; sha256 2fd83dca8a0ef99f82150dcfeb41768419556295a86ed38f712d631ed948c046},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180098. Agents can read the archived copy with the MCP tool read_document.